Cargando…

Breast cancer subtypes and survival in patients with brain metastases

INTRODUCTION: Brain metastases (BM) occur in up to one third of patients with metastatic breast cancer (MBC), whose incidences and prognoses by breast cancer subtypes in BM have not been well delineated. METHODS: Retrospective survival analyses were performed in 126 BM patients from 805 MBC patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nam, Byung-Ho, Kim, Sun Young, Han, Hye-Sook, Kwon, Youngmee, Lee, Keun Seok, Kim, Tae Hyun, Ro, Jungsil
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374976/ https://www.ncbi.nlm.nih.gov/pubmed/18307763 http://dx.doi.org/10.1186/bcr1870

Ejemplares similares

Potential antitumor effects of nitrogen-containing bisphosphonate in hormone receptor negative breast cancer patients with bone metastases
por: Park, In Hae, et al.
Publicado: (2009)

Impact of Molecular Subtype Conversion of Breast Cancers after Neoadjuvant Chemotherapy on Clinical Outcome
por: Lim, Siew Kuan, et al.
Publicado: (2016)

Locoregional Recurrence of Breast Conserving Surgery after Preoperative Chemotherapy in Korean Women with Locally Advanced Breast Cancer
por: Lee, Seeyoun, et al.
Publicado: (2011)

Primary Malignant Teratoma with a Primitive Neuroectodermal Tumor Component in Thyroid Gland : A Case Report
por: Kim, Eunyoung, et al.
Publicado: (2007)

Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study
por: Oh, Sang Woo, et al.
Publicado: (2011)

Outcomes of Palliative Weekly Low-Dose Gemcitabine-Cisplatin Chemotherapy in Anthracycline- and Taxane- Pretreated Metastatic Breast Cancer Patients
por: Kim, Jung Sun, et al.
Publicado: (2014)

The invasive lobular carcinoma as a prototype luminal A breast cancer: A retrospective cohort study
por: Jung, So-Youn, et al.
Publicado: (2010)

Breast Cancer–Related Lymphedema after Neoadjuvant Chemotherapy
por: Kim, Myungsoo, et al.
Publicado: (2015)

Brain metastases free survival differs between breast cancer subtypes
por: Berghoff, A, et al.
Publicado: (2012)

Prognostic Role of Interleukin-6, Interleukin-8, and Leptin Levels According to Breast Cancer Subtype
por: Cho, Young Ae, et al.
Publicado: (2013)

Locoregional Recurrence by Tumor Biology in Breast Cancer Patients after Preoperative Chemotherapy and Breast Conservation Treatment
por: Jwa, Eunjin, et al.
Publicado: (2016)

Survival outcomes of breast cancer patients with brain metastases: A multicenter retrospective study in Korea (KROG 16–12)
por: Kim, Jae Sik, et al.
Publicado: (2019)

Fatty fish and fish omega-3 fatty acid intakes decrease the breast cancer risk: a case-control study
por: Kim, Jeongseon, et al.
Publicado: (2009)

Survival outcomes of breast cancer patients with recurrence after surgery according to period and subtype
por: Lee, Young-jin, et al.
Publicado: (2023)

Protein and lipid MALDI profiles classify breast cancers according to the intrinsic subtype
por: Kang, Han Sung, et al.
Publicado: (2011)

Integrative In Vivo Drug Testing Using Gene Expression Signature and Patient-Derived Xenografts from Treatment-Refractory HER2 Positive and Triple-Negative Subtypes of Breast Cancer
por: Ryu, Jin-Sun, et al.
Publicado: (2019)

Subtypes of breast cancer show different spatial distributions of brain metastases
por: Kyeong, Sunghyon, et al.
Publicado: (2017)

Association of Polymorphisms and Haplotypes in the Insulin-Like Growth Factor 1 Receptor (IGF1R) Gene with the Risk of Breast Cancer in Korean Women
por: Kang, Han-Sung, et al.
Publicado: (2014)

Effects of Postoperative Radiotherapy on Leptomeningeal Carcinomatosis or Dural Metastasis after Resection of Brain Metastases in Breast Cancer Patients
por: Ha, Boram, et al.
Publicado: (2017)

A Case of Locally Advanced Breast Cancer Complicated by Pulmonary Tumor Thrombotic Microangiopathy
por: Kim, Hak Jin, et al.
Publicado: (2012)

Chromatin CKAP2, a New Proliferation Marker, as Independent Prognostic Indicator in Breast Cancer
por: Kim, Han-Seong, et al.
Publicado: (2014)

The Extent of Necrosis in Brain Metastases May Predict Subtypes of Primary Cancer and Overall Survival in Patients Receiving Craniotomy
por: Yoo, Jihwan, et al.
Publicado: (2022)

Combined Primary Tumor and Extracranial Metastasis Status as Constituent Factor of Prognostic Indices for Predicting the Overall Survival in Patients with Brain Metastases
por: Park, Young Hee, et al.
Publicado: (2013)

Subtype switching in breast cancer brain metastases: a multicenter analysis
por: Hulsbergen, Alexander F C, et al.
Publicado: (2020)

The influence of breast cancer subtype on survival after palliative radiation for osseous metastases
por: Abdelhakiem, Mohamed K., et al.
Publicado: (2020)

CKAP2 (cytoskeleton-associated protein2) is a new prognostic marker in HER2-negative luminal type breast cancer
por: Sim, Sung Hoon, et al.
Publicado: (2017)

Analysis of Prognostic Factors Affecting the Brain Metastases Free Survival and Survival After Brain Metastases in Breast Cancer
por: Xiao, Weikai, et al.
Publicado: (2020)

Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01)
por: Park, In Hae, et al.
Publicado: (2019)

Distinguishing Low-Risk Luminal A Breast Cancer Subtypes with Ki-67 and p53 Is More Predictive of Long-Term Survival
por: Lee, Se Kyung, et al.
Publicado: (2015)

Primary Primitive Neuroectodermal Tumor of the Breast: a Case Report
por: Ko, Kyungran, et al.
Publicado: (2009)

Clinical outcome of brain metastases differs significantly among breast cancer subtypes
por: Oehrlich, Nadja E., et al.
Publicado: (2017)

Analysis of Rates of Brain Metastases and Association With Breast Cancer Subtypes in Ontario, Canada
por: Wang, Xin Ye, et al.
Publicado: (2022)

Androgen Receptor Is Expressed in the Majority of Breast Cancer Brain Metastases and Is Subtype-Dependent
por: Fan, Kevin Yijun, et al.
Publicado: (2023)

Diagnostic Efficacy of PET/CT Plus Brain MR Imaging for Detection of Extrathoracic Metastases in Patients with Lung Adenocarcinoma
por: Lee, Ho Yun, et al.
Publicado: (2009)

Clinical outcomes of HER2-positive metastatic breast cancer patients with brain metastasis treated with lapatinib and capecitabine: an open-label expanded access study in Korea
por: Ro, Jungsil, et al.
Publicado: (2012)

Gamma Knife Radiosurgery for Brain Metastases from Breast Cancer
por: Jo, Kyung Il, et al.
Publicado: (2013)

Determining the Factors Predicting the Response to Anti-HER2 Therapy in HER2-Positive Breast Cancer Patients
por: You, Ji Young, et al.
Publicado: (2023)

Impact of Immunohistochemistry-Based Molecular Subtype on Chemosensitivity and Survival in Patients with Breast Cancer Following Neoadjuvant Chemotherapy
por: Yoo, Changhoon, et al.
Publicado: (2012)

Apparent diffusion coefficient histogram in breast cancer brain metastases may predict their biological subtype and progression
por: Ahn, Sung Jun, et al.
Publicado: (2018)

A Radiomics-Based Model for Potentially More Accurate Identification of Subtypes of Breast Cancer Brain Metastases
por: Cho, Seonghyeon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qm8icdh2dho6def45hugrak1hs